Blog
EBPMN – Biopharma in focus
By Mr Syed Ahmed, Vice President, EBPMN
As leaders in the biopharma industry in emerging economies, it is our responsibility to stay ahead of the curve and pave the way for innovation. The potential impact on patients’ lives is immense; by bringing cutting-edge treatments closer to those who need them most, we have the power to save lives and improve quality of life around the world.
Complex manufacturing requirements
By Tiago Rocca, Strategic Partnerships and BD Director, Instituto Butantan and Secretary, EBPMN.
The biopharmaceutical industry, one of the most dynamic, is continuously evolving, and an overview of 2023–2024 reveals several key trends and developments. From innovative new drugs to advancements in technology, the next few years promise to offer a lot of exciting developments.
Tackling Costs and Timelines in Biopharmaceuticals
By Dr Ebrahim Mohamed and BIOVAC, Head of Science and Innovation
As we all know, the field of biopharmaceuticals is one of the most crucial areas of healthcare research and has the boundless potential to revolutionize healthcare and provide better access to life-saving treatments. However, this industry faces numerous challenges, like excessive expenses and prolonged development timelines.